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SMALL VESSEL CORONARY OCCLUSIVE DISEASE AFTER CARDIAC 
TRANSPLANTATION 
Paul Wullins, John Scott, Dan Aravot, Steve Law 
John wallwork and Peter Schofield. 
Faust0 I. Pinto, Frederick G. St.Goar, Tim A. Fischell, Edwin L. 
~apuorth Hospital, Cambridge, England- Alderman, Michael L.&ad& Richard L. Popp. Stanford University Division of Cardiovascular Medicine. Stanford, CA 
c0-y occlusive disease (COD) is the main cau83 of 
graft failure after the first year in cardiac 
transplant recipients. The functional effects of this 
disce on the small resistance vessels are 88 yet 
unclear. we investigated the changes in coronary flow 
reserve (CPR) to the non specific smooth muscle 
vaaodilator papaverine. A 3P Doppler probe was 
inserted into the left anterior descending (LAS) 
coronary artery in 40 patienta following orthotopic 
heart transplantation. Studies were performed in 36 
males and 4 females with a mean age of 47.6 years 
(range 23-61). The median time from operation was 4 
years (range 3 months to 8 years). coronary flow 
reserve (CPR) was defined as the ratio of peak to 
resting velocities. The 16 patients with evidence of 
minor epicardial vessel disease (<25% stenosis) or 
aaall vessel disease in the LAD artery on angiography 
had a significantly reduced peek hyperaemic response to 
papaverine compared to the patients without COD (CPR 2. 
8 +/-1.15 VE 4.2 +/- 1.3, mean +/-lSD, pi o.m5). 
There uaB no correlation with age, original diagnosis, 
active rejection, blood pressure, HDL or LDL 
ChOleSterol levela. status, ischaemic time or 
cycloeporin levels. This demonstrates that significant 
reduction6 in non-endothelial dependent flow reserve 
Inuavascular ultrasound offers a new method for real-time evaluation 
of coronary vasomotion reponses to pharmacologic interventions. The 
coronary artery vasomotion response to nitroglycerin (NTG) was 
studied using a 5 French 30 mHz intracoronary ultrasound imaging 
catheter (CVIS, Inc) in 10 cardiac transplant recipients undergoing 
routine arteriograms 3 weeks to 9 years after transplantation. End 
diastolic cross sectional 1uminaI srea (L-CSA) and derived diameter (L- 
Dia) were measured at a fixed position in the left anterior descending 
coronary artery immediately before, and every thirty seconds for five 
minutes after, 0.4 mgs of sublingual NTG. All patients demonstrated 
a vasodilatory response to IUTG. Four patients bad biopsy proven mild 
or moderate rejection at the time of the studies. Results: L-CSA 
increased from a baseline of 13.5 mm* f 5.3 to 17.0 mm* f 4.7 at 
five minutes and L-Dia increased from 4.1 mm f 0.8 to 4.6 mm + 0.6. 
The increase reached statistical significance (~4.01) at 1.5 minutes 
after administration of NTG and the mean maximum increase occured 
at 4.5 minutes (34% for L-CSA and 14% for L-Dia). The NTG 
response was well preserved in patients up to 9 yrs after 
transplantation. Neither the coronary intimal thickness as measured 
with intravascular ultrasound nor the rejection status impacted the 
vasodilation response. 
preeent when 
;iographicaUy. 
only %inoP COD is seen 
Conclusion: intravascular ultrasound provides real time 
documentation of NTG-induced coronary vasodilation in cardiac 
transplant recipients. This response is well preserved in long term 
survivors and is not related to the degree of intimal disease or the 
presence of rejection. This suggests that medial muscular function is 
retained in transplant coronary arteries, including those with intimal 
proliferation. 
IDENTIFICATION OF TRANSPLANT ARTERIOPATHY IN 
ORTHOTOPIC CARDIAC TRANSPLANT RECIPIENTS USING 
EXERCISE SPECT THALLIUM -201 
, Christopher L. Hansen, Edward Lyons, Susan 
Brozena, Alan Mawr, Rick Vitti, Jeffrey Alpem. Temple University 
Hospital, Philadelphia, PA 
A major determinant of morbidity and mentality of cardiac transplant 
patients (Pts) is the development of transplant arteriopathy, which 
necessitates periodic cardiac catherization (cath). The purpose of this 
study was to determine the utility of exercise thaIlium-201 (Tl) 
sciniigraphy using single photon emission computed tomography 
(SPECT) in screening Pts for the presence of coronary artery disease 
(CAD). We evaluated 32 studies in 29 natients (28 men and 1 woman). 
who had ‘II and cath within 6 months. Patients were studied a mean of- 
3.6 years post-transplant. They exercised an average of 7.9k3.5 
minutes on the Bruce protocol, and attained maximal heart rates of 
135&24 beats per minute. 6 (19%) patients had abnormal 
electrocardiographic responses. Representative apical, mid and basal 
short axis thallium sections were selected and quantitated using radial 
profiles. The limits of normal were defined as 2.5 standard deviations 
below the mean of a previous9 defmed normal database. 
defined as abnormal if two 18 
A study was 
sectors were more than 2.5 standard 
deviations below the mean of the normals. A cath was considered 
abnormal if then was at least one vessel with a stenosis 2 50%. of the 
11 abnormal caths 9 showed defects on thallium imaging (Sensitivity = 
82%). Of the 21 normal caths 17 had normal thallium images 
(Specificity = 81%). Both false negatives were 1 vessel CAD (1 distal 
LAD, 1 septal). All 4 false positive thalliums were mild lateral defects 
and may reflect &teased attenuation of the lateml wall due to the 
increased clockwise rotation of the transplanted heart. We conclude 
that exercise Tl SPECI’ is effective for screening cardiac transplant 
mctpients for the presence of transplant arteriopathy. 
CORONARY RESPONSE TO NITROG IN CARDIA 
TRANSPLANT RECIPIENTS: TION WIT 
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Between 5/87 and 7/90 a group of high risk HTX 
patients (n=35) were selected to receive OKT3 
induction therapy (lo-14 days) with SEMI after 6 
weeks (cyclosporine and azathioprine only). 
This group was compared with a group of (HTX) 
patients (n=47) that received triple drug (TDI) 
inuaunosuppression (cyclosporine, azathioprine, 
and prednisone) during the same time interval. 
One and 3 year actuarial survival was 97% and 
91% (OKT3) and 91% and 85% (TDI). The incidence 
of freedom from rejection at 3 months and 1 year 
was 77% and 55% (OKT3) and 61% and 59% (TDI). 
The incidence of infection was higher during the 
initial 3 months in the OKT3 group (29% vs 6%) 
(p10.007). Six percent (TDI) vs 0% (OKT3) 
became diabetic post transplant. Total serum 
cholesterols (m&SD) were measured at intervals 
and are shown below: 
Pretransplant 
6 Months 
1 year 
oKT3 TDI p Value 
189&71 197256 n.s. 
207&54 250548 0.004 
205&59 260&56 0.003 
In conclusion, OKT3 induction 
HTX prevents tbe development of hypercholester- 
olemia and diabetes in treated patients, with no 
increase in mortality or incidence of rejection. 
